In the November 2024 Earnings call, Lantheus mentioned losing some clients to Illuccix. Their explanation was that these were customers that were more focussed on price and less about quality. Lantheus were not concerned about those accounts as they were small and Lantheus were focused on larger ones (to my recollection).
The earnings from Pylarify have continued to go down, leading not just to them missing estimates in the May 2025 earnings, but actually decreasing when over time. I find it strange that they now cite future competition, even including competitors that are yet to arrive after 2026! How can that be, if the TAM is growing, and as we know from Telix, Illuccix is growing into it?
Lantheus is failing to execute.
They are spending money poorly.
They look to be in serious trouble.
- Forums
- ASX - By Stock
- CU6 - Media and Industry News
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
0.00%
!
$4.33

In the November 2024 Earnings call, Lantheus mentioned losing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.33 |
Change
0.000(0.00%) |
Mkt cap ! $1.400B |
Open | High | Low | Value | Volume |
$4.31 | $4.44 | $4.20 | $11.74M | 2.723M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $4.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.34 | 132 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 4.310 |
2 | 12150 | 4.300 |
3 | 26354 | 4.260 |
1 | 360 | 4.250 |
3 | 19930 | 4.240 |
Price($) | Vol. | No. |
---|---|---|
4.340 | 132 | 1 |
4.350 | 22925 | 2 |
4.370 | 3500 | 1 |
4.380 | 5250 | 2 |
4.390 | 15000 | 3 |
Last trade - 16.16pm 30/07/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |